
Cases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.
Cases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.
Includes hair growth supplements and nicotine lozenges.
OTC cases focus on recommendations for vaccination boosters and managing fever.
Although second-generation antihistamines are preferred, patient preference should drive selection of therapy.
As the COVID-19 Public Health Emergency and PREP Act Expansions end, the ability of technicians to immunize patients in the future remains unclear.
Pharmacists play key roles in performing comprehensive patient reviews, reducing polypharmacy.
Guilty plea relates to shortcomings in recordkeeping of controlled substances 10 years earlier.
Law aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.
Mama Village Rx & Wellness cares for Mamaroneck community, owner considers patients like family.
More than 4 times as many people who used the app quit smoking compared to a traditional support service.
Leqembi is an intravenous injection for the treatment of Alzheimer disease.
The FDA approved a molecular test for emergency use and a supplemental new drug application for a blood sugar medication.
Products treat ulcerative colitis, urinary tract infection, and psoriatic arthritis.
Errors risk transmission of blood-borne pathogens, including HBV, HCV, HIV, to health care providers, patients.
Negative findings may spur choice of brand-name drugs, despite expense.
There are a multitude of benefits to smoking cessation, along with novel resources to make cessation more manageable.
Pharmacists should learn the basics of this leading cause of vision loss among adults worldwide.
Patients can employ numerous measures to alleviate pain, improve mobility, and boost overall health-related quality of life.
Acne, atopic dermatitis, rosacea, urticaria, and sunburn present differently and require specific management.
The DEA’s decision allows some health care providers to have more leeway in prescribing certain controlled substances.
Never have there been so many opportunities for non–dispensing pharmacist roles. At the same time, there has never been such a need to save the dispensing environment.